Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.580
+0.045 (0.99%)
Aug 7, 2026, 1:39 PM CET
Faes Farma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | - | 79.66 | 111.11 | 102.85 | 101.42 | 82.45 |
Depreciation & Amortization | 37.31 | 29.03 | 20.32 | 19.4 | 19.27 | 17.26 |
Stock-Based Compensation | 1.2 | 0.75 | 0.75 | - | - | - |
Other Adjustments | 9.53 | 16.17 | 2.39 | 3.74 | 4.49 | 16.3 |
Change in Receivables | -9.23 | -12.22 | -8.03 | - | - | -3.8 |
Changes in Inventories | -17.35 | -14.58 | -13.49 | - | - | -10.83 |
Changes in Accounts Payable | -10.03 | -0.86 | 16.12 | - | - | -6.86 |
Changes in Income Taxes Payable | -14.86 | -13.07 | -12.48 | -8.74 | -7.13 | -9.22 |
Changes in Other Operating Activities | -8.91 | -6.38 | -1.23 | -16.28 | -11.01 | -5.64 |
Operating Cash Flow | 80.36 | 78.49 | 115.47 | 100.97 | 107.04 | 79.65 |
Operating Cash Flow Growth | -20.55% | -32.02% | 14.36% | -5.67% | 34.40% | 1.47% |
Capital Expenditures | -17.83 | -16.11 | -33.81 | -102.19 | -80.95 | -51.49 |
Sale of Property, Plant & Equipment | 0.73 | 2.18 | 0.07 | - | 7.2 | 0.4 |
Purchases of Intangible Assets | -7.79 | -7.54 | -5.78 | - | - | -7.93 |
Purchases of Investments | -7.21 | -5.52 | -7.77 | -8.84 | -21.5 | - |
Proceeds from Sale of Investments | 2.64 | 0.2 | 13.11 | 18.22 | 2.82 | -1.88 |
Cash Acquisitions | -211.99 | -272.23 | - | -4.55 | - | -23.65 |
Proceeds from Business Divestments | - | - | - | - | - | 1.03 |
Other Investing Activities | - | - | - | - | - | 0.02 |
Investing Cash Flow | -242.05 | -299.02 | -34.18 | -97.36 | -92.43 | -83.49 |
Long-Term Debt Issued | 296.97 | 375 | - | 0.26 | 2.31 | - |
Long-Term Debt Repaid | -59.53 | -46.89 | -3.47 | -3.34 | -2.63 | -3.4 |
Net Long-Term Debt Issued (Repaid) | 237.44 | 328.11 | -3.47 | -3.08 | -0.31 | -3.4 |
Issuance of Common Stock | - | - | - | -17.69 | - | - |
Net Common Stock Issued (Repurchased) | - | - | - | -17.69 | - | - |
Common Dividends Paid | -55.72 | -55.72 | -48.24 | -14.61 | -18.15 | -13.72 |
Other Financing Activities | 0.32 | 1.23 | - | - | - | - |
Financing Cash Flow | 182.02 | 273.62 | -51.71 | -35.38 | -18.46 | -17.12 |
Net Cash Flow | 20.33 | 53.09 | 29.58 | -31.76 | -3.84 | -20.96 |
Free Cash Flow | 62.53 | 62.39 | 81.65 | -1.22 | 26.09 | 28.16 |
Free Cash Flow Growth | -38.17% | -23.60% | - | - | -7.32% | -51.69% |
FCF Margin | 8.58% | 283.54% | 362.83% | -0.26% | 5.74% | -265.76% |
Free Cash Flow Per Share | 0.20 | 0.20 | 0.26 | -0.00 | 0.09 | 0.09 |
Levered Free Cash Flow | 289.95 | 385.77 | 83.32 | -19 | 9.36 | 12.21 |
Unlevered Free Cash Flow | -6.01 | -508.9 | -420.86 | -16.15 | 9.68 | -364.22 |